Literature DB >> 10860902

Factors affecting adherence to antiretroviral therapy.

M A Chesney1.   

Abstract

In both clinical trials and clinical practice, nonadherence to medications is widespread among patients with chronic diseases. The shift to combination therapies for treating human immunodeficiency virus (HIV)-infected individuals has increased adherence challenges for both patients and health-care providers. Estimates of average rates of nonadherence to antiretroviral therapy range from 50% to 70%. Adherence rates of <80% are associated with detectable viremia in a majority of patients. The principal factors associated with nonadherence appear to be patient-related, including substance and alcohol abuse. However, other factors may also contribute, such as inconvenient dosing frequency, dietary restrictions, pill burden, and side effects; patient-health-care provider relationships; and the system of care. We discuss the major reasons reported by HIV-infected individuals for not taking their medications. Improving adherence probably requires clarifying the treatment regimen and tailoring it to patient lifestyles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10860902     DOI: 10.1086/313849

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  170 in total

1.  Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires.

Authors:  Leesa Giang; Christian P Selinger; Alice Unah Lee
Journal:  World J Hepatol       Date:  2012-02-27

2.  Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities.

Authors:  Lisa R Metsch; Margaret Pereyra; Carlos del Rio; Lytt Gardner; Wayne A Duffus; Gordon Dickinson; Peter Kerndt; Pamela Anderson-Mahoney; Steffanie A Strathdee; Alan E Greenberg
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

3.  Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.

Authors:  T C Do; D Boettiger; M Law; S Pujari; F Zhang; R Chaiwarith; S Kiertiburanakul; M P Lee; R Ditangco; W W Wong; K V Nguyen; T P Merati; T T Pham; A Kamarulzaman; S Oka; E Yunihastuti; N Kumarasamy; P Kantipong; J Y Choi; O T Ng; N Durier; K Ruxrungtham
Journal:  HIV Med       Date:  2016-08       Impact factor: 3.180

4.  A Study of Compliance to Antiretroviral Therapy among HIV Infected Patients at a Tertiary Care Hospital in North Karnataka.

Authors:  Ishwar Siddappa Hasabi; Arun Beekanahalli Shivashankarappa; Chandrashekar Kachapur; Ram Suresh Kaulgud
Journal:  J Clin Diagn Res       Date:  2016-05-01

5.  A Markov Model to Estimate Mortality Due to HIV/AIDS Using Viral Load Levels-Based States and CD4 Cell Counts: A Principal Component Analysis Approach.

Authors:  Claris Shoko; Delson Chikobvu; Pascal O Bessong
Journal:  Infect Dis Ther       Date:  2018-11-02

6.  The relationship between HIV/Sexually Transmitted Infection risk and alcohol use during commercial sex episodes: results from the study of female commercial sex workers in the Philippines.

Authors:  Chi Chiao; Donald E Morisky; Rhonda Rosenberg; Kate Ksobiech; Robert Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

7.  Coping with HIV treatment side effects: conceptualization, measurement, and linkages.

Authors:  Mallory O Johnson; Torsten B Neilands
Journal:  AIDS Behav       Date:  2007-04-11

Review 8.  Pharmacotherapy of pediatric HIV infection.

Authors:  Natella Rakhmanina; B Ryan Phelps
Journal:  Pediatr Clin North Am       Date:  2012-08-22       Impact factor: 3.278

Review 9.  Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.

Authors:  Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell
Journal:  AIDS Behav       Date:  2014-04

Review 10.  Drug compliance in adolescents: assessing and managing modifiable risk factors.

Authors:  Betty Staples; Terrill Bravender
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.